Anti-drug antibodies were also made against long acting

New Post Public Reply Private Reply Replies (2) Message Board
MGK_2 Katangolo #145421
832
Anti-drug antibodies were also made against long acting leronlimab.

What is really interesting to me is the situation where the macaque developed the anti-drug antibodies, then completely stopped making leronlimab. Then, after a year of making zero leronlimab, spontaneously started making leronlimab all over again, by itself. There was no re-injection of AAV to initiate that spontaneous resurgence of the auto-manufacture of leronlimab.

First off, in order to develop anti-drug antibodies, something had to tell the immune system that the self-produced leronlimab were foreign. Then the immune system went through the process of developing its immune response against it and ended up with anti-drug antibodies against that leronlimab.

The immune system ramped up its production of the anti-drug antibodies to render the auto-produced leronlimab useless and maintained an undetectable level of that leronlimab in the blood serum for a year.

Then, all of a sudden, leronlimab was measured again in the blood serum spontaneously, without re-injection of the AAV delivery system.

Let's take the perspective that the leronlimab which was being made in the body was considered an antigen. However, not a very robust antigen. Let's consider that the body perceived it to be something like a "dead" virus. Therefore, we can consider that the self-produced leronlimab was perceived by the body to even be a "vaccine" against what would be the live virus, ie, the live leronlimab which really does not exist, but the body does not know that..

So, initially, the body develops its initial response to the dead virus and develops sufficient response as antibodies which drop leronlimab down to zero detectable in the serum.

But, with repeated doses of the "dead" virus, as the body continues to manufacture the self producing leronlimab, which is "the vaccine", the auto-produced leronlimab, the body became increasingly fatigued of producing any further antibody against it, In essence, after repeated bombardment of vaccination after vaccination after vaccination, it no longer considered the dead virus to be foreign. Rather, it began to consider it as self.

The T-Regs / Suppressor cells became increasingly convinced that this auto produced leronlimab was self. and suppressed the B-Cells from making any more antibodies.

 
Consider this video from 6 minute time to the 14 minute

Germinal Centers/url]

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 1

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 2

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
Midea's VitaBreeze: Revolutionizing Personalized Climate

Updated Category News Views 5

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
TCL’s AI Vision: Immersive Living at IFA 2026

Updated Category News Views 0

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 11

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading

Top 5 Most Recently Viewed Articles

Anika Therapeutics Shows Recovery in Q3 2024 Performance

Updated Category News Views 46

Anika Therapeutics Reports Q3 2024 Financials In a significant move, Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in joint preservation, has reported its financial results for the third quarter ending September 30, 2024. This release follows the company’s strategic decisions to pivot its focus towards high-growth segments within the orthopedic industry. Key...

Continue Reading
Red Cat Secures $20 Million Funding for Drone Innovation

Updated Category News Views 328

Red Cat's Strategic Shift in Drone Technology Funding Red Cat Holdings, Inc. (Nasdaq: RCAT), a leader in drone technology designed for military, government, and commercial applications, has recently announced a significant financial move. The company secured an agreement for up to $20 million in debt financing, with the initial tranche of $16.5 million already completed....

Continue Reading
Investing in Alamos Gold: A 5-Year Performance Review

Updated Category News Views 84

Understanding Alamos Gold's Investment Potential Alamos Gold (NYSE: AGI) has shown impressive performance in the market over the past five years, boasting an annualized return of 27.3%. This strong growth has allowed the company to outperform the market by a significant margin of 12.72% annually. With a current market capitalization of approximately $8.42 billion, Alamos...

Continue Reading
Explore Phemex's Revolutionary 24/7 Futures Trading Hub

Updated Category News Views 135

Phemex Launches 24/7 TradFi Futures Trading Phemex, a user-focused cryptocurrency exchange, has recently announced an exciting development in trading: the introduction of their traditional finance (TradFi) futures trading. This innovative offering allows users to access a variety of traditional financial assets, including stocks and precious metals, at any time of the day...

Continue Reading
Kraig Biocraft Laboratories Announces New Production Milestone

Updated Category News Views 64

Kraig Biocraft Laboratories Reaches Remarkable Production Goal Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has recently made headlines by completing a noteworthy production cycle that resulted in the delivery of over one million BAM-1 Alpha hybrid eggs. This significant achievement marks a pivotal moment for the company as they look to amplify their production...

Continue Reading